FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Floxuridine for Injection, USP
Status: Currently in Shortage
»Date first posted: 09/16/2020
»Therapeutic Categories: Oncology

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Reverified 04/08/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg per vial (NDC 0143-9270-01) Currently available Additional lots are scheduled for manufacturing. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English